Literature DB >> 8657332

Serial positron emission tomography imaging of changes in amino acid metabolism in low grade astrocytoma after radio- and chemotherapy-- Case report.

K Sato1, M Kameyama, T Kayama, T Yoshimoto, K Ishiwata, M Ito.   

Abstract

A 37-year-old male with mixed glioma was treated with combined radio- and chemotherapy. The amino acid metabolism of the tumor site and normal brain was followed by positron emission tomography using [11C]methionine ([11C]Met). The accumulation of [11C]Met in the tumor decreased during therapy and slightly increased 7 months after completion of the therapy, but then decreased markedly. However, computed tomography revealed no notable changes. The contralateral gray matter also showed a gradual decrease of [11C]Met accumulation. These findings indicate that reduction of amino acid metabolism in the tumor continues after radiochemotherapy although neuroimaging reveals no further morphological changes. Such therapy also has long-term effects on normal brain tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8657332     DOI: 10.2176/nmc.35.808

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  3 in total

1.  A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET.

Authors:  Mitsuhiko Hasebe; Kyosan Yoshikawa; Seiya Ohashi; Sachiko Toubaru; Koji Kawaguchi; Junichi Sato; Junetsu Mizoe; Hirohiko Tsujii
Journal:  Mol Imaging Biol       Date:  2010-10       Impact factor: 3.488

Review 2.  A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy.

Authors:  Carol L Armstrong; Kunsang Gyato; Abdel W Awadalla; Robert Lustig; Zelig A Tochner
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

Review 3.  Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring.

Authors:  Amarnath Challapalli; Eric O Aboagye
Journal:  Front Oncol       Date:  2016-02-29       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.